Monashee Investment Management LLC Acelrx Pharmaceuticals Inc Transaction History

Monashee Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$2.1 - $3.93 $393,099 - $735,656	-187,190 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$2.35 - $3.83 $3.44 Million - $5.61 Million	-1,465,000 Reduced 88.67%	187,190 $651,000
Q4 2018 Feb 12, 2019	BUY	$2.13 - $4.8 $3.3 Million - $7.44 Million	1,550,000 Added 1516.78%	1,652,190 $3.82 Million
Q3 2018 Nov 13, 2018	BUY	$2.6 - $4.6 $265,694 - $470,073	102,190 New	102,190 $393,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.